Risk of secondary leukemia following high cumulative doses of etoposide during chemotherapy for testicular cancer

J Natl Cancer Inst. 1995 Jan 4;87(1):58-60. doi: 10.1093/jnci/87.1.58.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Etoposide / administration & dosage
  • Etoposide / adverse effects*
  • Etoposide / therapeutic use
  • Humans
  • Leukemia / chemically induced*
  • Male
  • Neoplasms, Second Primary / chemically induced*
  • Testicular Neoplasms / drug therapy*

Substances

  • Etoposide